微博
加入微博一起分享新鲜事
登录
|
注册
140
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial https://icostatistics.no/publication/troseid-efficacy-2023/
请登录并选择要私信的好友
300
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial https://icostatistics.no/publication/troseid-efficacy-2023/
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候